Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status

Jithma P. Abeykoon, Karen L. Rech, Jason R. Young, Aishwarya Ravindran, Gordon J. Ruan, Surendra Dasari, Diana M. Morlote, Rebecca L. King, Claire Rummage, Saurabh Zanwar, Aldo M. Acosta-Medina, W. Oliver Tobin, Mithun V. Shah, N. Nora Bennani, Robert Vassallo, Jay H. Ryu, Matthew J. Koster, Caroline J. Davidge-Pitts, Thomas E. Witzig, Gaurav GoyalRonald S. Go

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status'. Together they form a unique fingerprint.

Medicine & Life Sciences